West Pharmaceutical Services, Inc. (WST) Shares Bought by Russell Investments Group Ltd.

Russell Investments Group Ltd. increased its holdings in West Pharmaceutical Services, Inc. (NYSE:WST) by 66.9% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 14,028 shares of the medical instruments supplier’s stock after purchasing an additional 5,625 shares during the period. Russell Investments Group Ltd.’s holdings in West Pharmaceutical Services were worth $1,326,000 as of its most recent SEC filing.

Other large investors have also made changes to their positions in the company. Harfst & Associates Inc. purchased a new stake in shares of West Pharmaceutical Services in the first quarter valued at $186,000. Tyers Asset Management LLC grew its position in shares of West Pharmaceutical Services by 17.6% in the first quarter. Tyers Asset Management LLC now owns 2,464 shares of the medical instruments supplier’s stock valued at $201,000 after purchasing an additional 368 shares during the period. Cambridge Investment Research Advisors Inc. grew its position in shares of West Pharmaceutical Services by 1.6% in the first quarter. Cambridge Investment Research Advisors Inc. now owns 2,569 shares of the medical instruments supplier’s stock valued at $210,000 after purchasing an additional 40 shares during the period. Koch Industries Inc. purchased a new stake in shares of West Pharmaceutical Services in the first quarter valued at $225,000. Finally, Zurcher Kantonalbank Zurich Cantonalbank grew its position in shares of West Pharmaceutical Services by 22.1% in the first quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,792 shares of the medical instruments supplier’s stock valued at $228,000 after purchasing an additional 505 shares during the period. 91.25% of the stock is owned by institutional investors and hedge funds.

Shares of West Pharmaceutical Services, Inc. (WST) traded up 4.61% during midday trading on Friday, hitting $95.91. The stock had a trading volume of 761,446 shares. The firm has a 50-day moving average price of $87.41 and a 200-day moving average price of $89.29. The firm has a market cap of $7.10 billion, a price-to-earnings ratio of 41.16 and a beta of 1.13. West Pharmaceutical Services, Inc. has a 1-year low of $70.17 and a 1-year high of $99.91.

West Pharmaceutical Services (NYSE:WST) last issued its quarterly earnings results on Thursday, July 27th. The medical instruments supplier reported $0.66 EPS for the quarter, topping the consensus estimate of $0.65 by $0.01. West Pharmaceutical Services had a net margin of 11.42% and a return on equity of 14.02%. The firm had revenue of $397.60 million for the quarter, compared to analysts’ expectations of $406.00 million. During the same period in the previous year, the firm posted $0.59 EPS. The company’s revenue for the quarter was up 2.5% on a year-over-year basis. On average, equities analysts anticipate that West Pharmaceutical Services, Inc. will post $2.68 EPS for the current fiscal year.

The company also recently announced a quarterly dividend, which will be paid on Wednesday, November 1st. Stockholders of record on Wednesday, October 18th will be issued a $0.14 dividend. This represents a $0.56 dividend on an annualized basis and a dividend yield of 0.58%. This is a boost from West Pharmaceutical Services’s previous quarterly dividend of $0.13. The ex-dividend date is Tuesday, October 17th. West Pharmaceutical Services’s dividend payout ratio is presently 22.22%.

ILLEGAL ACTIVITY WARNING: “West Pharmaceutical Services, Inc. (WST) Shares Bought by Russell Investments Group Ltd.” was originally posted by TrueBlueTribune and is the sole property of of TrueBlueTribune. If you are reading this news story on another site, it was illegally copied and reposted in violation of United States and international copyright and trademark laws. The original version of this news story can be viewed at https://www.truebluetribune.com/2017/09/17/west-pharmaceutical-services-inc-wst-shares-bought-by-russell-investments-group-ltd.html.

A number of equities research analysts have recently commented on the company. Jefferies Group LLC reaffirmed a “hold” rating and issued a $90.00 price objective on shares of West Pharmaceutical Services in a research report on Thursday, June 8th. Zacks Investment Research raised West Pharmaceutical Services from a “hold” rating to a “strong-buy” rating and set a $114.00 price target for the company in a research report on Friday, June 9th. Finally, BidaskClub downgraded West Pharmaceutical Services from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, June 13th. Two equities research analysts have rated the stock with a sell rating and three have assigned a buy rating to the company. West Pharmaceutical Services presently has a consensus rating of “Hold” and an average target price of $98.52.

West Pharmaceutical Services Profile

West Pharmaceutical Services, Inc is a manufacturer of packaging components and delivery systems for injectable drugs and healthcare products. The Company’s products include vial containment solutions, prefillable systems, self-injection platforms, cartridge systems and components, reconstitution and transfer systems, intradermal delivery solutions, specialty components, and contract manufacturing and analytical services.

Institutional Ownership by Quarter for West Pharmaceutical Services (NYSE:WST)

Receive News & Ratings for West Pharmaceutical Services Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for West Pharmaceutical Services Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply